Quarterly report · Q1
4521.TEDINET S100RKL3
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.1bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥73.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.2bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥3.3bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥4.1bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥3.5bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.3bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.5bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.0bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.5bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.9bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.5bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥2.9bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥167.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥166.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥165.1bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.3bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥29.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥137.8bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥136.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥137.9bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥56.8bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥59.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥66.99 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.8 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.91 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E00935-000Medicinereportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥17.5bn |
| jpcrp040300-q1r_E00935-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥17.5bn |
| jpcrp040300-q1r_E00935-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q1r_E00935-000Real Estatereportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥605m |
| jpcrp040300-q1r_E00935-000Real Estatereportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥605m |
| jpcrp040300-q1r_E00935-000Real Estatereportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥321m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥18.1bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥18.1bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥3.3bn |
| jpcrp040300-q1r_E00935-000Medicinereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥17.6bn |
| jpcrp040300-q1r_E00935-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥17.6bn |
| jpcrp040300-q1r_E00935-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥3.8bn |
| jpcrp040300-q1r_E00935-000Real Estatereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥615m |
| jpcrp040300-q1r_E00935-000Real Estatereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥615m |
| jpcrp040300-q1r_E00935-000Real Estatereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥295m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥18.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥18.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥4.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 374
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss attributable to owners of parent | Prior1YTDDuration | 2907000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 2510000000 | JPY |
| Profit loss | Prior1YTDDuration | 2907000000 | JPY |
| Profit loss | CurrentYTDDuration | 2510000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 90000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 1301000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 15000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -1000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 106000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 1300000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 3014000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 3810000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 3014000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 3810000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | - | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | - | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember | 17088000000 | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember | - | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_ReportableSegmentsMember | 17088000000 | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration | 17088000000 | JPY |
| Royalty | Prior1YTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember | 494000000 | JPY |
| Royalty | Prior1YTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember | - | JPY |
| Royalty | Prior1YTDDuration_ReportableSegmentsMember | 494000000 | JPY |
| Royalty | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Royalty | Prior1YTDDuration | 494000000 | JPY |
| Other income | Prior1YTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember | - | JPY |
| Other income | Prior1YTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember | 615000000 | JPY |
| Other income | Prior1YTDDuration_ReportableSegmentsMember | 615000000 | JPY |
| Other income | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Other income | Prior1YTDDuration | 615000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember | 17582000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember | 615000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 18197000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1YTDDuration | 18197000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember | 17582000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember | 615000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 18197000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Net sales | Prior1YTDDuration | 18197000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00935-000MedicineReportableSegmentsMember | 3760000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00935-000RealEstateReportableSegmentsMember | 295000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 4056000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |